# Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary Syndrome

> **NCT00911313** · NA · COMPLETED · sponsor: **Mansoura University** · enrollment: 250 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Letrozole tablets (Femara; Novartis Pharma, Switzerland)
- **DRUG:** metformin HCl (Cidophage®; CID,Cairo, Egypt)
- **DRUG:** CC (Clomid®; Global Napi Pharmaceuticals, Cairo, Egypt)

## Key facts

- **NCT ID:** NCT00911313
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2009-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911313, "Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00911313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*